Activity of convalescent and vaccine serum against a B.1.1.529 variant SARS-CoV-2 isolate
preprint
OA: gold
CC-BY-NC-ND-4.0
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (23)
- Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern via crossref
- Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa via crossref
- Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and Monoclonal Antibodies via crossref
- SARS-CoV-2 B.1.1.529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals via crossref
- SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection via crossref
- doi:10.1038/s41591-019-0463-x via crossref
- doi:10.1016/j.vaccine.2021.05.063 via crossref
- doi:10.1016/j.cell.2021.06.005 via crossref
- doi:10.1038/s41586-021-03738-2 via crossref
- doi:10.1056/nejmc2101667 via crossref
- doi:10.1126/science.abc1917 via crossref
- doi:10.1038/s41591-020-0913-5 via crossref
- doi:10.1002/cpmc.100 via crossref
- doi:10.3791/51112 via crossref
- doi:10.1128/msphere.00189-18 via crossref
- doi:10.1002/cpmc.108 via crossref
- doi:10.1038/s41586-020-2180-5 via crossref
- doi:10.3201/eid2802.212422 via crossref
- doi:10.1126/science.abc6952 via crossref
- doi:10.1056/nejmc2114706 via crossref
- doi:10.1016/j.ebiom.2021.103626 via crossref
- doi:10.1038/nm.3443 via crossref
- doi:10.1128/jvi.01696-18 via crossref
Source provenance
- crossref
- last seen: 2026-06-13T06:42:38.438376+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-05-21T02:00:01.467718+00:00
License: CC-BY-NC-ND-4.0